Steward Partners Investment Advisory’s OKYO Pharma OKYO Stock Holding History

Steward Partners Investment Advisory’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9K	Buy	+6,000	New	+$9.61K	﹤0.01%	3777

Other funds holding OKYO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steward Partners Investment Advisory's OKYO Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in OKYO Pharma (OKYO) in Q2 2026: 6,000 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #3777 among its holdings.

16 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

Steward Partners Investment Advisory held 6,000 shares of OKYO Pharma worth $9K as of Q2 2026.
OKYO Pharma was a new Steward Partners Investment Advisory position in Q2 2026.
OKYO Pharma made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3777 holding.
16 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.